A comprehensive view of Clinical Trials. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer launches Phase 1 clinical trial for PF-06954522, a new potential treatment for type 2 diabetes and obesity, with plans to recruit 122 American adult participants

Sarah Cannon Research Institute partners with AstraZeneca to offer clinical trial solutions in US cancer studies to speed up trial delivery, reduce site burden and boost enrollment; deal will involve trial network of more than 250 locations in 24 states

Pfizer reports its bivalent vaccine ABRYSVO maintains high protective efficacy for both RSV A and RSV B disease in adults aged 60 or older through two seasons after one dose; RSV infections account for approximately 60,000-160,000 hospitalizations in US

Pre-clinical study demonstrates benefits to skin structure from using Lycored's Lumenato with ceramides; combining even low concentrations of ceramides with Lumenato result in synergistic effects that lead to high levels of protection from collagen loss

AstraZeneca ends collaboration with FibroGen on oral anemia drug roxadustat following FDA rejection, returns rights to the drug in the US and several other countries; AstraZeneca retains interest in China and South Korea where the drug has been approved

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count